retatrutide phase 2 trial results Triple–Hormone-Receptor Agonist for Obesity — A | NEJM Results of a new medication,

The combined therapy with liraglutide and metformin (COMBI) seems to be more effective

What will delay you getting that drug is cold chain logistics and pharmacies buying itor not buying itwhere youre located, Chase explained

& Ali, N

Sodium-glucose cotransporter-2 (SGLT-2) inhibitor use was associated with reduced cardiovascular events and mortality compared to placebo in the Empagliflozin Cardiovascular Outcome Event Trial in Type 2 diabetes Mellitus Patients (EMPA-REG OUTCOME), CANagliflozin cardioVascular Assessment Study (CANVAS), and Dapagliflozin Effect on Cardiovascular Events Thrombolysis in Myocardial Infarction 58 (DECLARE-TIMI58) trials

What might be the optimal injection timing during early titration phases may not be the same consideration at a maintenance dose where side effects are minimal

These data also highlight some inconsistencies in the interpretations of the effects of GLP1 in the arcuate nucleus